International PatientsNewsContact
HACETTEPE UNIVERSITYHOSPITALS
Appointment
EN
  1. Home
  2. Doctors
  3. Assoc. Prof. Dr. Neslihan Akdoğan
Assoc. Prof. Dr. Neslihan Akdoğan

Assoc. Prof. Dr.

Neslihan Akdoğan

Dermatology · Adult Hospital

Dermatoloji
Appointment0312 305 17 04

Education

  1. 2020- Halen
    Deri ve Zührevi Hastalıklar (Dr. Öğretim Üyesi)
    Hacettepe Üniversitesi
  2. 2018-2020
    Deri ve Zührevi Hastalıklar (Öğretim Görevlisi)
    Hacettepe Üniversitesi
  3. 2008-2013
    MSc — Deri ve Zührevi Hastalıklar
    Hacettepe Üniversitesi
  4. 2002-2008
    Tıp Fakültesi
    Hacettepe Üniversitesi

Expertise

Dermatoloji

Publications

Source: Hacettepe University academic database (AVESİS) · All publications (62) ↗

Articles 57

  1. Lower body mass index was an independent factor of omalizumab dose escalation in adult patients with chronic spontaneous urticariaBalan K., AKDOĞAN N., Memisoglu I. B., ZEYREK M., GÜLSEREN D., Armagan B. Y., et al.Archives of Dermatological Research, cilt.318, sa.1, 2026 (SCI-Expanded, Scopus)
  2. Tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa: a case-control studyYel B., GÜNDOĞAN H., DURMAZ ÖZDİNÇ C. D., KARABULUT E., AKDOĞAN N.Archives of Dermatological Research, cilt.318, sa.1, 2026 (SCI-Expanded, Scopus)
  3. Clinical and Direct Immunofluorescence Correlates of Systemic Involvement in Leukocytoclastic VasculitisBalan K., AKDOĞAN N., Memisoglu I. B., Terzi L. H., YALICI ARMAĞAN B., GÜLSEREN D., et al.Australasian Journal of Dermatology, cilt.67, sa.6, 2026 (SCI-Expanded, Scopus)
  4. Clinical Characteristics, Genomic Sequencing, and Treatment Response of 13 Cases Infected With the Emerging Pathogen, Trichopyhton indotineae, From TürkiyeAKDOĞAN N., Kaymak M. K., BOŞNAK C., SÖNMEZER M. Ç., GÜLMEZ KIVANÇ D., POLAT C., et al.International Journal of Dermatology, cilt.65, sa.8, ss.1668-1675, 2026 (SCI-Expanded, Scopus)
  5. Guselkumab associated nephrotic syndrome: A case report of membranous nephropathy Síndrome nefrótico asociado al guselkumab: un caso clínico de nefropatía membranosaCANDER N. F., HABERAL G., AYDIN F., NOYAN A., AKDOĞAN N., YETER H. H.Nefrologia, cilt.46, sa.6, 2026 (Scopus)
  6. Patterns and pitfalls: Dermoscopic differentiation of early-stage mycosis fungoides, atopic dermatitis, and psoriasisBalan K., Lallas A., AKDOĞAN N.Journal of the American Academy of Dermatology, cilt.94, sa.4, ss.1193-1198, 2026 (SCI-Expanded, Scopus)
  7. Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysisAKDOĞAN N., MUTLU Ö. K., KARABULUT E., YALICI ARMAĞAN B., GÜLSEREN D., DOĞAN GÜNAYDIN S.EXPERT REVIEW OF CLINICAL PHARMACOLOGY, cilt.18, sa.6, ss.417-423, 2025 (SCI-Expanded, Scopus)
  8. Acute Localized Exanthematous Pustulosis in a 5-Year-Old Boy With Zosteriform DistrubitonBalan K., Aydin F., AKDOĞAN N.CUREUS JOURNAL OF MEDICAL SCIENCE, sa.7, 2024 (ESCI)
  9. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective studyTabak G. H., AKDOĞAN N., DOĞAN GÜNAYDIN S., PARLAR Y. E., BALABAN H. Y., ŞİMŞEK H.ARCHIVES OF DERMATOLOGICAL RESEARCH, cilt.316, sa.5, 2024 (SCI-Expanded, Scopus)
  10. Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasisAKDOĞAN N., Balan K., YALICI ARMAĞAN B., GÜLSEREN D., DOĞAN GÜNAYDIN S.EXPERT REVIEW OF CLINICAL PHARMACOLOGY, cilt.17, sa.8, ss.755-762, 2024 (SCI-Expanded, Scopus)
  11. Bizarre Cutaneous Ulcers due to Self-Administered Intravenous Dexketoprofen TrometamolAKDOĞAN N., ELÇİN G., KİRAZ S.INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, cilt.22, sa.4, ss.788-791, 2023 (SCI-Expanded, Scopus)
  12. Nicolau Syndrome Secondary to Subcutaneous Glatiramer Acetate InjectionDemircan C., AKDOĞAN N., Elmas L.International Journal of Lower Extremity Wounds, cilt.22, sa.1, ss.149-151, 2023 (SCI-Expanded, Scopus)
  13. Clonal B-cell proliferations developing in the background of primary cutaneous CD4(+) small/medium T-cell lymphoproliferative disorder: A case seriesOzdemir D. A., AKDOĞAN N., Okay M., ÜNER A., Saglam A.JOURNAL OF CUTANEOUS PATHOLOGY, cilt.49, sa.11, ss.971-977, 2022 (SCI-Expanded, Scopus)
  14. A diagnostic challenge: Pathergy positivity in papulopustular lesions of Behçet disease mimicking acute localised exanthematous pustulosisBostan E., GÜLSEREN D., AKDOĞAN N., FOTO ÖZDEMİR D., KARADAĞ Ö.Indian Journal of Dermatology, Venereology and Leprology, cilt.88, sa.6, ss.817-819, 2022 (SCI-Expanded, Scopus)
  15. Diagnostic Role of Direct Immunofluorescence Assay in Determining The Etiology of Erythroderma: Experience in a Tertiary Referral HospitalBostan E., GÖKÖZ Ö., Dogan S., GÜLSEREN D., AKDOĞAN N., YALICI ARMAĞAN B., et al.Dermatology Practical and Conceptual, cilt.12, sa.4, 2022 (SCI-Expanded, Scopus)
  16. Extradigital Glomus Tumor of the ArmElmas L., AKDOĞAN N., GÖKÖZ Ö.DERMATOLOGIC SURGERY, cilt.48, sa.10, ss.1119-1120, 2022 (SCI-Expanded, Scopus)
  17. Impact of COVID-19 Pandemic on Hidradenitis Suppurativa Patients: a Cross-Sectional Study From Tertiary Referral HospitalBostan E., Jarbou A., KARADUMAN A., GÜLSEREN D., YALICI ARMAĞAN B., AKDOĞAN N.Dermatology Practical and Conceptual, cilt.12, sa.4, 2022 (SCI-Expanded, Scopus)
  18. The emergence of morphea in a patient undergoing ustekinumab therapy given for psoriasisTABAK G. H., AKDOĞAN N., YEL B., GÖKÖZ Ö.DERMATOLOGIC THERAPY, cilt.35, sa.9, 2022 (SCI-Expanded, Scopus)
  19. Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasisDURMUŞ Ö., AKDOĞAN N., KARADAĞ Ö., GÖKÖZ Ö.DERMATOLOGIC THERAPY, cilt.35, sa.5, 2022 (SCI-Expanded, Scopus)
  20. Clinical and Histopathological Characteristics of Cutaneous Metastases from Solid Organ Cancers: Experience of Dermatology in a Tertiary Referral HospitalBOSTAN E., AKDOĞAN N., GÖKÖZ Ö.TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY, cilt.16, sa.2, ss.44-51, 2022 (ESCI, Scopus)
  21. Cutaneous metastasis of breast carcinoma presenting as milia-en-plaqueTabak G. H., AKDOĞAN N., ATEŞ ÖZDEMİR D.JOURNAL OF COSMETIC DERMATOLOGY, cilt.21, sa.3, ss.1297-1299, 2022 (SCI-Expanded, Scopus)
  22. Dermatology consultation requests from a university hospital's pediatric and adult emergency departments: A 5-year retrospective analysisDEMİREL ÖĞÜT N., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., AKDOĞAN N., DOĞAN GÜNAYDIN S., ELÇİN G., et al.AMERICAN JOURNAL OF EMERGENCY MEDICINE, cilt.53, ss.112-117, 2022 (SCI-Expanded, Scopus)
  23. New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptinBOSTAN E., Yel B., AKDOĞAN N., GÖKÖZ Ö.DERMATOLOGIC THERAPY, cilt.35, 2022 (SCI-Expanded, Scopus)
  24. Monitoring serum lipid profile and liver transaminase levels during isotretinoin therapyGÜLSEREN BÜYÜKDOĞAN D., BOSTAN E., AKDOĞAN N., YALICI ARMAĞAN B., DOĞAN GÜNAYDIN S., ERSOY EVANS S., et al.Acta Medica, cilt.53, sa.2, 2022 (TRDizin)
  25. New onset mitral regurgitation caused by mitral valve prolapse in a male patient with dominant pretibial dystrophic epidermolysis bullosaUysal P., AKDOĞAN N., Cavdarli B., Kahraman D., Berkalp B., GÖKÖZ Ö.Indian Journal of Dermatology, cilt.67, sa.1, ss.72-74, 2022 (SCI-Expanded, Scopus)
  26. Possible case of mRNA COVID-19 vaccine-induced small-vessel vasculitisBOSTAN E., Zaid F., AKDOĞAN N., GÖKÖZ Ö.JOURNAL OF COSMETIC DERMATOLOGY, cilt.21, sa.1, ss.51-53, 2022 (SCI-Expanded, Scopus)
  27. Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centreTerzi L. H., AKDOĞAN N., DOĞAN GÜNAYDIN S., Atakan N.INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, cilt.75, sa.12, 2021 (SCI-Expanded, Scopus)
  28. Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantationAKDOĞAN N., ERSOY EVANS S., Visal Okur F., KUŞKONMAZ B. B., ÇETİNKAYA F. D.BONE MARROW TRANSPLANTATION, cilt.56, sa.11, ss.2866-2868, 2021 (SCI-Expanded, Scopus)
  29. Early recognition of chronic rejection in a face allotransplant patient with alopeciaAKDOĞAN N., ERSOY EVANS S., GÖKÖZ Ö., ERDEM Y., Nasir S.JOURNAL OF CUTANEOUS PATHOLOGY, cilt.48, sa.10, ss.1286-1297, 2021 (SCI-Expanded, Scopus)
  30. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Analysis of 23 PatientsYALICI ARMAĞAN B., Demircan C., AKDOĞAN N., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., ELÇİN G., et al.Acta Medica, cilt.52, sa.3, ss.239-243, 2021 (TRDizin)
  31. Sarcoid-like granulomatous reaction in the lung mimicking miliary tuberculosis in a patient receiving adalimumab for psoriasisAKDOĞAN N., DOĞAN GÜNAYDIN S., Bayler R., KÖKSAL D., Onder S.ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.3, ss.461-463, 2021 (SCI-Expanded, Scopus, TRDizin)
  32. Stevens Johnson Syndrome and toxic epidermal necrolysis: a retrospective anaylsis of 23 patientsYALICI ARMAĞAN B., demircan c., AKDOĞAN N., GÜLSEREN BÜYÜKDOĞAN D., DOĞAN GÜNAYDIN S., ELÇİN G., et al.Acta Medica, cilt.52, sa.3, 2021 (TRDizin)
  33. Severe hidradenitis suppurativa (acne inversa) associated with focal segmental glomerulosclerosis and gout partially responsive to canakinumabAKDOĞAN N., YALICI ARMAĞAN B., DOĞAN GÜNAYDIN S., Yilmaz R.DERMATOLOGIC THERAPY, cilt.34, sa.4, 2021 (SCI-Expanded, Scopus)
  34. Acne inversa-like lesions and acneiform eruption associated with vemurafenib and cobimetinib used for advanced melanomaBOSTAN E., AKDOĞAN N.JOURNAL OF COSMETIC DERMATOLOGY, cilt.20, sa.6, ss.1944-1945, 2021 (SCI-Expanded, Scopus)
  35. Epidermodysplasia Verruciformis After Hematopoietic Stem Cell Transplantation in a Patient With Severe Combined Immunodeficiency Syndrome.Bostan E., Akdogan N., Gokoz Ö.The American Journal of dermatopathology, cilt.43, 2021 (SCI-Expanded, Scopus)
  36. Ixekizumab-induced alopecia with folliculitis decalvans-like presentationAKDOĞAN N., GÖKÖZ Ö.DERMATOLOGIC THERAPY, cilt.34, sa.2, 2021 (SCI-Expanded, Scopus)
  37. Hydroxychloroquine treatment for Alopecia Universalis: Report of six casesAKDOĞAN N., ERSOY EVANS S.AUSTRALASIAN JOURNAL OF DERMATOLOGY, cilt.62, sa.1, 2021 (SCI-Expanded, Scopus)
  38. Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasisAKDOĞAN N., DOĞAN GÜNAYDIN S., BOSTAN E., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., ELÇİN G., et al.EXPERT REVIEW OF CLINICAL PHARMACOLOGY, cilt.14, sa.12, ss.1535-1541, 2021 (SCI-Expanded, Scopus)
  39. Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapyAKDOĞAN N., DOĞAN GÜNAYDIN S., GÜLSEREN D., YALICI ARMAĞAN B., ERSOY EVANS S., Elcin G., et al.DERMATOLOGIC THERAPY, cilt.34, sa.1, 2021 (SCI-Expanded, Scopus)
  40. New-onset psoriasiform dermatitis in a patient treated with nivolumab for sarcomatoid carcinoma of the head and neckSeyit M. V., AKDOĞAN N., YALICI ARMAĞAN B., ATEŞ ÖZDEMİR D.DERMATOLOGIC THERAPY, cilt.34, sa.1, 2021 (SCI-Expanded, Scopus)
  41. Lactate dehydrogenase, Beta-2 Microglobulin Levels and CD4/CD8 Lymphocyte Ratio in Patients with Mycosis Fungoides in Stage 1AGÜLSEREN BÜYÜKDOĞAN D., BOSTAN E., DOĞAN GÜNAYDIN S., YALICI ARMAĞAN B., AKDOĞAN N., ERSOY EVANS S., et al.Acta Medica, cilt.51, sa.4, ss.16-21, 2020 (TRDizin)
  42. The effect of warts on quality of life in Turkish pediatric patientsAKDOĞAN N., KOÇ YILDIRIM S., Kultur E., Evans S.TURKISH JOURNAL OF PEDIATRICS, cilt.62, sa.6, ss.1028-1034, 2020 (SCI-Expanded, Scopus, TRDizin)
  43. Rapid response to combination of hydroxychloroquine and prednisolone in a patient with refractory hypocomplementemic urticarial vasculitisBOSTAN E., AKDOĞAN N., GÖKÖZ Ö., DOĞAN GÜNAYDIN S.DERMATOLOGIC THERAPY, cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)
  44. A case of lichenoid mycosis fungoides that became apparent after penicillin treatment for secondary syphilisAKDOĞAN N., BOSTAN E., ATEŞ ÖZDEMİR D., ERSOY EVANS S.DERMATOLOGIC THERAPY, cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)
  45. Successful treatment of a patient with linearIgAbullous dermatosis limited to oral, hypopharyngeal, and laryngeal mucosa with dapsoneElmas L., Akdoğan N., Yılmaz T.DERMATOLOGIC THERAPY, cilt.33, sa.6, 2020 (SCI-Expanded, Scopus)
  46. Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center studyAKDOĞAN N., Dogan S., Atakan N.JOURNAL OF DERMATOLOGICAL TREATMENT, cilt.31, sa.7, ss.702-706, 2020 (SCI-Expanded, Scopus)
  47. Poikiloderma with Neutropenia, Clericuzio-Type Accompanied by Loss of Digits Due to Severe OsteomyelitisAKDOĞAN N., KINDIŞ E., BOSTAN E., Utine E., ALİKAŞİFOĞLU M., ERSOY EVANS S.JOURNAL OF CLINICAL IMMUNOLOGY, cilt.40, sa.6, ss.934-939, 2020 (SCI-Expanded, Scopus)
  48. Granuloma faciale arising on a scar after Mohs surgery for basal cell carcinomaAKDOĞAN N., ELÇİN G., KAVUNCUOĞLU A., GÖKÖZ Ö.JOURNAL OF COSMETIC DERMATOLOGY, cilt.19, sa.7, ss.1807-1809, 2020 (SCI-Expanded, Scopus)
  49. Acute generalized exanthematous pustulosis induced by iron carboxymaltose infusion: A case reportBOSTAN E., YALÇIN H. B., AKDOĞAN N., ATEŞ ÖZDEMİR D., KARADUMAN A.DERMATOLOGIC THERAPY, cilt.33, sa.3, 2020 (SCI-Expanded, Scopus)
  50. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' diseaseHuseynova L., AKDOĞAN N., GÖKÖZ Ö., ERSOY EVANS S.ANAIS BRASILEIROS DE DERMATOLOGIA, cilt.95, sa.3, ss.336-339, 2020 (SCI-Expanded, Scopus)
  51. The co-existence of cutaneous melanoma and urticaria pigmentosa in a patient with Becker's nevusAKDOĞAN N., ELÇİN G., GÖKÖZ Ö.JOURNAL OF COSMETIC DERMATOLOGY, cilt.19, sa.5, ss.1268-1270, 2020 (SCI-Expanded, Scopus)
  52. Amyloid light-chain amyloidosis with haemorrhagic bullous eruption disclosing multiple myelomaIncel Uysal P., AKDOĞAN N., Bozdogan O., Ozhamam E., Cakmak S., Yalcin B.INTERNATIONAL WOUND JOURNAL, cilt.17, sa.2, ss.510-513, 2020 (SCI-Expanded, Scopus)
  53. Indeterminate cell histiocytosis in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome: an unusual associationAKDOĞAN N., Demircan C., BÖLEK E. Ç., GÖKÖZ Ö., Karaduman A.LUPUS, cilt.29, sa.1, ss.74-78, 2020 (SCI-Expanded, Scopus)
  54. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areataAKDOĞAN N., ERSOY EVANS S., Dogan S., Atakan N.DERMATOLOGIC THERAPY, 2019 (SCI-Expanded, Scopus)
  55. Long-term effects of omalizumab on peripheral blood cells and C-reactive protein levels in patients with chronic spontaneous urticariaAKDOĞAN N., DEMİREL ÖĞÜT N., Dogan S., Atakan N.DERMATOLOGIC THERAPY, cilt.32, sa.4, 2019 (SCI-Expanded, Scopus)
  56. Factors Affecting the Etiology of Intractable Pruritus in Hospitalized Patients Without Primary Skin LesionsAkdogan N., Uysal P. I., Oktem A., KARABULUT E., Hayran Y., Yalcin B.ISTANBUL MEDICAL JOURNAL, cilt.20, sa.3, ss.224-230, 2019 (ESCI, TRDizin)
  57. Primary Lymphocytic Cicatricial Alopecia: A Retrospective Analysis of 36 PatientsAKDOĞAN N., KARADUMAN A., ERSOY EVANS S., Hapa A., ELÇİN G., Erkin G., et al.ISTANBUL MEDICAL JOURNAL, cilt.18, sa.4, ss.218-221, 2017 (ESCI, TRDizin)

Conference papers 5

  1. The Effect Of Covid- 19 On Patients With Chronic Spontaneous Urticaria: A Cross- Sectional, Comparative StudyBOSTAN E., Zaid F., KARADUMAN A., DOĞAN GÜNAYDIN S., GÜLSEREN BÜYÜKDOĞAN D., AKDOĞAN N., et al.International Congress on Scientific Advances (ICONSAD’21), Türkiye, 22 - 25 Aralık 2021, (Özet Bildiri)
  2. Hacettepe Üniversite Hastanesi’nde Çocuk ve Erişkin Acil Servis’lerinden yapılan dermatoloji konsültasyon istemleri: 5 yıllık bir retrospektif değerlendirmeDEMİREL ÖĞÜT N., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., AKDOĞAN N., DOĞAN GÜNAYDIN S., ELÇİN G., et al.Dermatolojide ve Kozmetolojide Gelişmeler Kongresi 2021, İzmir, Türkiye, 18 - 22 Ağustos 2021, ss.40, (Özet Bildiri)
  3. COVİD-19 pandemisinin dermatolojik yakınmalar ile gerçekleşen acil servis başvuruları üzerine etkisiDEMİREL ÖĞÜT N., TABAK H., GÜLSEREN BÜYÜKDOĞAN D., YALICI ARMAĞAN B., AKDOĞAN N., DOĞAN GÜNAYDIN S., et al.Sanal Dermatoloji Buluşması, ONLİNE, 12 - 14 Şubat 2021, ss.75, (Özet Bildiri)
  4. Mikozis Fungoideste Hastalık Evresi ile Laboratuvar Parametrelerinin İlişkisiGÜLSEREN BÜYÜKDOĞAN D., BOSTAN E., DOĞAN GÜNAYDIN S., YALICI ARMAĞAN B., AKDOĞAN N., ERSOY EVANS S., et al.28. ULUSAL DERMATOLOJİ KONGRESİ, Türkiye, 24 - 29 Eylül 2019, (Özet Bildiri)
  5. Psöriazisli hastalarda psoriatik artrit tarama araçlarında kullanılan parametrelerin performansı: Sistematik literatür taramasıAYAN G., CAN G., BEKTAŞ M., ÖZDEDE A., AKDOĞAN N., YALICI ARMAĞAN B., et al.

Contact

Phone
0312 305 17 04
Department
Dermatology, Adult Hospital

Last updated: